NCT03487445: A reported trial by Idorsia Pharmaceuticals Ltd.
This trial has reported on time, in line with the regulations.
Full data
Full entry on ClinicalTrials.gov | NCT03487445 |
---|---|
Title | A Multi-center, Open-label, Randomized, Study to Assess the Onset of Platelet Aggregation Inhibition After a Single Subcutaneous Injection of ACT-246475 in Adults With Acute Myocardial Infarction |
Results Status | Reported |
ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
Start date | July 10, 2018 |
Completion date | Nov. 10, 2018 |
Required reporting date | Nov. 10, 2021, midnight |
Actual reporting date | July 30, 2021 |
Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
Days late | None |